Dividend Calculator Dividend Returns Comparison Dividend Calendar

My Experts Top Analysts Top Financial Bloggers Top-Performing Corporate Insiders Top Hedge Fund Managers Top Research Firms Top Individual Investors

Education

Personal Finance How To Use TipRanks TipRanks Labs Webinar Center Glossary FAQs

About Us

About TipRanks Contact Us Careers Reviews Mobile APP

Working with TipRanks

Enterprise Solutions Advertise with Us Top Online Brokers Become an Affiliate TipRanks News Wire

TOOLS

Top Smart Score Stocks

STOCKS

Research Tools

Most Visited Websites

Daily Feeds

Daily Analyst Ratings

Daily Insider Trading Tracker

Calendars

Economic Indicators

Economic Indicators Center

Inflation Rate

Unemployment Rate

Federal Funds Rate

Class Actions

Calculators

Dividend Calculator

Dividend Yield Calculator

Options Profit Calculator

Dollar Cost Averaging

Technical Analysis Screener

Dividend Center

Best Dividend Stocks

Popular

Best High Yield Dividend Stocks

Dividend Aristocrats

Dividend Stock Comparison

New

Dividend Calculator

Dividend Returns Comparison

Dividend Calendar

Top Analysts

Top Financial Bloggers

Top-Performing Corporate Insiders

Top Hedge Fund Managers

Top Research Firms

Top Individual Investors

News

Portfolio

Personal Finance Center

Mortgages

Loans

Investing & Retirement

Spending & Savings

Calculators

Compound Interest Calculator

Student Loan Calculator

401k Retirement Calculator

Education

About Us

Working with TipRanks

Biocryst Pharmaceuticals (DE:BO1)

FRANKFURT:BO1

BO1

BioCryst

RESEARCH TOOLS

Top Smart Score Stocks

Stock Screener

reports

Holding DE:BO1?

Track your performance easily

Link Broker

BioCryst (BO1) Stock News & Sentiment

1 Followers

BioCryst Pharmaceuticals Reports Strong Q3 2024 Results

Premium

Company Announcements

BioCryst Pharmaceuticals Reports Strong Q3 2024 Results

2M ago

BCRX

BioCryst Announces Strong Q3 2024 Revenue Growth

Premium

Company Announcements

BioCryst Announces Strong Q3 2024 Revenue Growth

2M ago

BCRX

Premium

Pre-Earnings

BioCryst Pharmaceuticals (BCRX) Q3 Earnings Cheat Sheet

2M ago

BCRX

Premium

Market News

Two Key Products Drive BioCryst (BCRX) to New Highs

3M ago

BCRX

BioCryst Begins Phase 1 Trial for Netherton Syndrome Treatment

Premium

Company Announcements

BioCryst Begins Phase 1 Trial for Netherton Syndrome Treatment

3M ago

BCRX

BioCryst Secures Major US Health Department Influenza Drug Deal

Premium

Company Announcements

BioCryst Secures Major US Health Department Influenza Drug Deal

3M ago

BCRX

BioCryst Clarifies Recent Report’s Regulatory Significance

Premium

Company Announcements

BioCryst Clarifies Recent Report’s Regulatory Significance

5M ago

BCRX

More BCRX News >

BO1 News on the Web

2024-11-04

BioCryst’s Orladeyo Drives Strong Performance and Growth Potential, Earning a Buy Rating

TipRanks News

Bullish

2024-11-04

BioCryst Pharmaceuticals (BCRX) Reports Q3 Loss, Tops Revenue Estimates

Zacks

Neutral

2024-10-23

How Much Upside is Left in BioCryst (BCRX)? Wall Street Analysts Think 79.5%

Zacks

Bullish

2024-10-21

BioCryst to Report Third Quarter 2024 Financial Results on November 4

Yahoo Finance

Neutral

2024-10-14

BioCryst to Present New Real-World Evidence Showing Significant Reductions in Medical Visits and Hospitalizations After Starting ORLADEYO®

Yahoo Finance

Neutral

2024-10-11

Is BioCryst Pharmaceuticals, Inc. The Top Stock With Improving Technical Ratings According To Piper Sandler?

Yahoo Finance

Neutral

2024-10-10

RSI Alert: BioCryst Pharmaceuticals (BCRX) Now Oversold

BNK Invest

Neutral

2024-10-10

BioCryst to Present New Real-World Evidence on Long-Term Prophylaxis in HAE, including ORLADEYO® , at the American College of Allergy, Asthma & Immunology 2024 Annual Scientific Meeting

Yahoo Finance

Neutral

News Score - Last 7 Days

Not enough data to generate a sentiment score

Media Buzz

This Week0 articles

Weekly Average0 articles

News Sentiment

Currently, no data available

See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is DE:BO1’s Media Buzz Sentiment?

Currently, no data Available

What is DE:BO1’s weekly average amount of articles?

Currently, no data Available

What is DE:BO1’s News Sentiment?

Currently, no data Available

Healthcare Stocks that are Trending in the News

VRDNViridian Therapeutics

ANNXAnnexon Biosciences

LRMRLarimar Therapeutics

MCKMcKesson

TEVATeva Pharmaceutical

Showing the stocks with the most bullish news sentiment over the past week

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing